{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,2]],"date-time":"2026-06-02T05:41:26Z","timestamp":1780378886083,"version":"3.54.1"},"reference-count":0,"publisher":"Informa UK Limited","license":[{"start":{"date-parts":[[2014,5,1]],"date-time":"2014-05-01T00:00:00Z","timestamp":1398902400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/3.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["CEG"],"DOI":"10.2147\/ceg.s45261","type":"journal-article","created":{"date-parts":[[2014,5,23]],"date-time":"2014-05-23T02:20:33Z","timestamp":1400811633000},"page":"163","source":"Crossref","is-referenced-by-count":6,"title":["Is there a role for vedolizumab in the treatment of ulcerative colitis and Crohn’s disease?"],"prefix":"10.2147","author":[{"given":"Patrick","family":"Allen","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Leah","family":"Gilroy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"301","published-online":{"date-parts":[[2014,5]]},"container-title":["Clinical and Experimental Gastroenterology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.dovepress.com\/getfile.php?fileID=20163","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2016,10,30]],"date-time":"2016-10-30T22:24:53Z","timestamp":1477866293000},"score":1,"resource":{"primary":{"URL":"http:\/\/www.dovepress.com\/is-there-a-role-for-vedolizumab-in-the-treatment-of-ulcerative-colitis-peer-reviewed-article-CEG"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,5]]},"references-count":0,"URL":"https:\/\/doi.org\/10.2147\/ceg.s45261","relation":{},"ISSN":["1178-7023"],"issn-type":[{"value":"1178-7023","type":"electronic"}],"subject":[],"published":{"date-parts":[[2014,5]]}}}